Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04401748
PHASE3

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

Sponsor: AbbVie

View on ClinicalTrials.gov

Summary

Myelodysplastic Syndrome (MDS) is a group of disorders that gradually affect the ability of a person's bone marrow (semi-liquid tissue present in many bones like backbones) to produce normal blood cells. Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk of death from the disease itself. Symptoms of MDS include fatigue, shortness of breath, unusual paleness due to anemia (low red blood cell count), easy or unusual bruising, and red spots just beneath the skin caused by bleeding. The purpose of this study is to see how safe and effective venetoclax and azacitidine (AZA) combination are when compared to AZA and a placebo (contains no medicine), in participants with newly diagnosed higher-risk MDS. Venetoclax is an investigational drug being developed for the treatment of MDS. The study consists of two treatment arms - In one arm, participants will receive venetoclax and AZA. In another arm, participants will receive AZA and placebo. Adult participants with newly diagnosed higher-risk MDS will be enrolled. Around 500 participants will be enrolled in approximately 220 sites worldwide. Participants in one arm will receive oral doses of venetoclax tablet and intravenous (infusion in the vein) or subcutaneous (given under the skin) AZA solution. Participants in another arm will receive oral doses of placebo tablet and intravenous or subcutaneous AZA solution. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the course of the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood and bone marrow tests, checking for side effects, and completing questionnaires.

Official title: A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Azacitidine in Patients Newly Diagnosed With Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

531

Start Date

2020-09-10

Completion Date

2027-07

Last Updated

2026-05-06

Healthy Volunteers

No

Interventions

DRUG

Venetoclax

Tablet: Oral

DRUG

Azacitidine

Subcutaneous (SC) or Intravenous (IV) injection

DRUG

Placebo

Tablet; Oral

Locations (220)

Duplicate_Providence Medical Foundation /ID# 222633

Fullerton, California, United States

University of California, Los Angeles /ID# 221760

Los Angeles, California, United States

Torrance Memorial Physician Network Cancer Care /ID# 222702

Torrance, California, United States

PIH Health Whittier Hospital /ID# 222647

Whittier, California, United States

Rocky Mountain Cancer Centers - Boulder /ID# 223723

Boulder, Colorado, United States

Yale University School of Medicine /ID# 222764

New Haven, Connecticut, United States

Helen F. Graham Cancer Center & Research Institute /ID# 223731

Newark, Delaware, United States

Florida Cancer Specialists - Fort Myers /ID# 221319

Fort Myers, Florida, United States

Memorial Healthcare System /ID# 222703

Hollywood, Florida, United States

Florida Cancer Specialists - North /ID# 221318

St. Petersburg, Florida, United States

Florida Cancer Specialists - Panhandle /ID# 221315

Tallahassee, Florida, United States

Florida Cancer Specialists - East /ID# 221317

West Palm Beach, Florida, United States

St. Luke's Mountain State Tumor Institute /ID# 220838

Boise, Idaho, United States

Northwestern University Feinberg School of Medicine /ID# 220843

Chicago, Illinois, United States

Duplicate_Rush University Medical Center /ID# 221007

Chicago, Illinois, United States

Ingalls Memorial Hosp /ID# 220844

Harvey, Illinois, United States

Illinois Cancer Care, PC /ID# 220840

Peoria, Illinois, United States

Duplicate_Parkview Cancer Institute /ID# 223620

Fort Wayne, Indiana, United States

Cancer Center of Kansas /ID# 222648

Wichita, Kansas, United States

Hematology/Oncology Clinic /ID# 224257

Baton Rouge, Louisiana, United States

Pontchartrain Cancer Center - Covington /ID# 221005

Covington, Louisiana, United States

Maryland Oncology Hematology /ID# 223776

Columbia, Maryland, United States

Massachusetts General Hospital /ID# 225068

Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center /ID# 225069

Boston, Massachusetts, United States

Dana-Farber Cancer Institute /ID# 219162

Boston, Massachusetts, United States

VA Ann Arbor Healthcare System /ID# 221365

Ann Arbor, Michigan, United States

Cancer & Hematology Centers /ID# 220848

Grand Rapids, Michigan, United States

Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 221321

Saint Louis Park, Minnesota, United States

MidAmerica Division, Inc. /ID# 221895

Kansas City, Missouri, United States

Comprehensive Cancer Centers of Nevada - Horizon Ridge /ID# 222635

Henderson, Nevada, United States

Titan Health Partners LLC, d/b/a Astera Cancer Care /ID# 221003

East Brunswick, New Jersey, United States

The Valley Hospital /ID# 232337

Paramus, New Jersey, United States

New York Oncology Hematology - Albany Cancer Center /ID# 223778

Albany, New York, United States

University at Buffalo /ID# 221206

Buffalo, New York, United States

Weill Cornell Medical College /ID# 222898

New York, New York, United States

Stony Brook University Hospital /ID# 224450

Stony Brook, New York, United States

Novant Health Presbyterian Medical Center /ID# 222561

Charlotte, North Carolina, United States

Novant Health Forsyth Medical Center /ID# 221004

Winston-Salem, North Carolina, United States

Oncology Hematology Care, Inc. /ID# 223724

Cincinnati, Ohio, United States

Bend Memorial Clinic /ID# 220999

Bend, Oregon, United States

Willamette Valley Cancer Institute and Research Center /ID# 223733

Eugene, Oregon, United States

UPMC Hillman Cancer Ctr /ID# 223201

Pittsburgh, Pennsylvania, United States

Avera Cancer Institute /ID# 243461

Sioux Falls, South Dakota, United States

Tennessee Oncology - Chattanooga / McCallie /ID# 221311

Chattanooga, Tennessee, United States

Tennessee Oncology-Nashville Centennial /ID# 220854

Nashville, Tennessee, United States

Texas Oncology - Austin Midtown /ID# 223729

Austin, Texas, United States

Duplicate_Texas Oncology - Medical City Dallas /ID# 223725

Dallas, Texas, United States

Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 223727

Dallas, Texas, United States

Texas Oncology - Forth Worth /ID# 223777

Fort Worth, Texas, United States

MD Anderson Cancer Center at Texas Medical Center /ID# 219163

Houston, Texas, United States

Texas Oncology - San Antonio Medical Center - Research Drive /ID# 223728

San Antonio, Texas, United States

Baylor Scott & White Medical Center- Temple /ID# 221332

Temple, Texas, United States

Texas Oncology - Northeast Texas /ID# 223734

Tyler, Texas, United States

Utah Cancer Specialists Salt Lake Clinic /ID# 219160

Salt Lake City, Utah, United States

Virginia Cancer Specialists - Gainesville /ID# 223726

Gainesville, Virginia, United States

Virginia Commonwealth University Medical Center Main Hospital /ID# 221590

Richmond, Virginia, United States

Virginia Cancer Institute at Reynolds Crossing /ID# 221002

Richmond, Virginia, United States

VA Puget Sound Health Care System /ID# 221358

Seattle, Washington, United States

Duplicate_Blacktown Hospital /ID# 234079

Blacktown, New South Wales, Australia

St George Hospital /ID# 221810

Kogarah, New South Wales, Australia

Port Macquarie Base Hospital /ID# 234078

Port Macquarie, New South Wales, Australia

Gold coast University Hospital /ID# 222606

Southport, Queensland, Australia

Royal Adelaide Hospital /ID# 221805

Adelaide, South Australia, Australia

St Vincent's Hospital Melbourne /ID# 221809

Fitzroy Melbourne, Victoria, Australia

Austin Health /ID# 221807

Heidelberg, Victoria, Australia

Medizinische Universitaet Wien /ID# 221446

Vienna, State of Vienna, Austria

Ordensklinikum Linz GmbH Elisabethinen /ID# 221387

Linz, Upper Austria, Austria

Klinikum Wels-Grieskirchen GmbH /ID# 221386

Wels, Upper Austria, Austria

Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221092

Salzburg, Austria

Hanusch Krankenhaus /ID# 221093

Vienna, Austria

ZAS Middelheim /ID# 218907

Antwerp, Antwerpen, Belgium

Cliniques Universitaires UCL Saint-Luc /ID# 219066

Brussels, Brussels Capital, Belgium

Hospital La Louviere Site Jolimont - Helora /ID# 218921

La Louvière, Hainaut, Belgium

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant /ID# 219064

Yvoir, Namur, Belgium

UZ Gent /ID# 218767

Ghent, Oost-Vlaanderen, Belgium

Universitair Ziekenhuis Leuven /ID# 218905

Leuven, Vlaams-Brabant, Belgium

AZ Sint-Jan Brugge /ID# 218212

Bruges, West-Vlaanderen, Belgium

Hospital Universitario Walter Cantidio /ID# 223434

Fortaleza, Ceará, Brazil

Hospital Erasto Gaertner /ID# 221341

Curitiba, Puerto Rico, Brazil

Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein /ID# 221370

São Paulo, São Paulo, Brazil

Hospital Universitário Pedro Ernesto /ID# 223080

Rio de Janeiro, Brazil

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 221339

São Paulo, Brazil

BC Cancer - Surrey /ID# 219098

Surrey, British Columbia, Canada

Ottawa Hospital Research Institute /ID# 219105

Ottawa, Ontario, Canada

Sunnybrook Health Sciences Centre /ID# 219103

Toronto, Ontario, Canada

McGill University Health Centre - Glen Site /ID# 222519

Montreal, Quebec, Canada

CIUSSS du Nord-de-l'ile-de-Montréal_Hopital du Sacré-Coeur de Montréal /ID# 218973

Montreal, Quebec, Canada

CHUQ- Hôpital de l'Enfant-Jesus /ID# 221200

Québec, Quebec, Canada

Peking University International Hospital /ID# 222987

Beijing, Beijing Municipality, China

Lanzhou University Second Hospital /ID# 225980

Lanzhou, Gansu, China

Guangdong Provincial People's Hospital /ID# 221442

Guangzhou, Guangdong, China

Zhujiang Hospital of Southern Medical University /ID# 222071

Guangzhou, Guangdong, China

Nanfang Hospital of Southern Medical University /ID# 224566

Guangzhou, Guangdong, China

The Second Hospital of Hebei Medical University /ID# 222919

Shijiazhuang, Hebei, China

People's Hospital of Henan Province /ID# 225790

Zhengzhou, Henan, China

Henan Cancer Hospital /ID# 221447

Zhengzhou, Henan, China

Union Hospital affiliated to Tongji Medical College of Huazhong University of Sc /ID# 221475

Wuhan, Hubei, China

Tongji Hospital Tongji Medical College of HUST /ID# 221474

Wuhan, Hubei, China

Zhongda Hospital Southeast University /ID# 221849

Nanjing, Jiangsu, China

Jiangsu Province Hospital /ID# 221342

Nanjing, Jiangsu, China

And 120 more locations on ClinicalTrials.gov